A design for external quality assessment for the analysis of thiopurine drugs: pitfalls and opportunities

Karen Robijns, Matthijs van Luin, Rob T. P. Jansen, Cees Neef, Daan J. Touw

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1715-1721
Number of pages7
JournalClinical Chemistry and Laboratory Medicine
Volume56
Issue number10
DOIs
Publication statusPublished - 1 Oct 2018

Keywords

  • external quality assessment scheme
  • harmonization
  • thiopurine drugs
  • RED-BLOOD-CELLS
  • CONTROL PROGRAM
  • 6-THIOGUANINE NUCLEOTIDES
  • ANTIRETROVIRAL DRUGS
  • 6-MERCAPTOPURINE
  • DISEASE
  • PLASMA

Cite this

@article{33eabdc314214cdda554a3ca4a95e970,
title = "A design for external quality assessment for the analysis of thiopurine drugs: pitfalls and opportunities",
keywords = "external quality assessment scheme, harmonization, thiopurine drugs, RED-BLOOD-CELLS, CONTROL PROGRAM, 6-THIOGUANINE NUCLEOTIDES, ANTIRETROVIRAL DRUGS, 6-MERCAPTOPURINE, DISEASE, PLASMA",
author = "Karen Robijns and {van Luin}, Matthijs and Jansen, {Rob T. P.} and Cees Neef and Touw, {Daan J.}",
year = "2018",
month = "10",
day = "1",
doi = "10.1515/cclm-2018-0116",
language = "English",
volume = "56",
pages = "1715--1721",
journal = "Clinical Chemistry and Laboratory Medicine",
issn = "1434-6621",
publisher = "Walter de Gruyter GmbH",
number = "10",

}

A design for external quality assessment for the analysis of thiopurine drugs: pitfalls and opportunities. / Robijns, Karen; van Luin, Matthijs; Jansen, Rob T. P.; Neef, Cees; Touw, Daan J.

In: Clinical Chemistry and Laboratory Medicine, Vol. 56, No. 10, 01.10.2018, p. 1715-1721.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - A design for external quality assessment for the analysis of thiopurine drugs: pitfalls and opportunities

AU - Robijns, Karen

AU - van Luin, Matthijs

AU - Jansen, Rob T. P.

AU - Neef, Cees

AU - Touw, Daan J.

PY - 2018/10/1

Y1 - 2018/10/1

KW - external quality assessment scheme

KW - harmonization

KW - thiopurine drugs

KW - RED-BLOOD-CELLS

KW - CONTROL PROGRAM

KW - 6-THIOGUANINE NUCLEOTIDES

KW - ANTIRETROVIRAL DRUGS

KW - 6-MERCAPTOPURINE

KW - DISEASE

KW - PLASMA

U2 - 10.1515/cclm-2018-0116

DO - 10.1515/cclm-2018-0116

M3 - Article

VL - 56

SP - 1715

EP - 1721

JO - Clinical Chemistry and Laboratory Medicine

JF - Clinical Chemistry and Laboratory Medicine

SN - 1434-6621

IS - 10

ER -